The impact of vascular burden on late-life depression

Brain Research Reviews

Volumn 62, Issue 1, 2009, Pages 19-32

  Santos, Micaela ^a   Kövari, Enikö ^a   Hof, Patrick R ^c   Gold, Gabriel ^a   Bouras, Constantin ^a   Giannakopoulos, Panteleimon ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b University of Lausanne Medical Center   (Switzerland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cognitive impairment; Lacunes; Microvascular pathology; Mood; Vascular burden

Indexed keywords

AGING; BASAL GANGLION; BRAIN CORTEX; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMYELINATION; DEPRESSION; ELDERLY CARE; ENDOTHELIAL DYSFUNCTION; HUMAN; MOOD DISORDER; NEUROIMAGING; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; THALAMUS; WHITE MATTER;

AGING; BLOOD VESSELS; BRAIN; COGNITION DISORDERS; DEPRESSIVE DISORDER; HUMANS;

EID: 70449624835     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.08.003     Document Type: Review

References (218)

1. Aben I., Lodder J., Honig A., Lousberg R., Boreas A., and Verhey F. Focal or generalized vascular brain damage and vulnerability to depression after stroke: a 1-year prospective follow-up study. Int. Psychogeriatr. 18 (2006) 19-35
2. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., and Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 54 (1997) 915-922
3. Alexopoulos G.S., Meyers B.S., Young R.C., Kalayam B., Kakuma T., Gabrielle M., Sirey J.A., and Hull J. Executive dysfunction and long-term outcomes of geriatric depression. Arch. Gen. Psychiatry 57 (2000) 285-290
4. Alexopoulos G.S. New concepts for prevention and treatment of late-life depression. Am. J. Psychiatry 158 (2001) 835-838
5. Alexopoulos G.S., Buckwalter K., Olin J., Martinez R., Wainscott C., and Krishnan K.R. Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biol. Psychiatry 52 (2002) 543-558
6. Alexopoulos G.S., Kiosses D.N., Klimstra S., Kalayam B., and Bruce M.L. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am. J. Geriatr. Psychiatry 10 (2002) 98-106
7. Alexopoulos G.S. Vascular disease, depression, and dementia. J. Am. Geriatr. Soc. 51 (2003) 1178-1180
8. Alexopoulos G.S., Murphy C.F., Gunning-Dixon F.M., Latoussakis V., Kanellopoulos D., Klimstra S., Lim K.O., and Hoptman M.J. Microstructural white matter abnormalities and remission of geriatric depression. Am. J. Psychiatry 165 (2008) 238-244
9. Almeida O.P., Flicker L., Norman P., Hankey G.J., Vasikaran S., van Bockxmeer F.M., and Jamrozik K. Association of cardiovascular risk factors and disease with depression in later life. Am. J. Geriatr. Psychiatry 15 (2007) 506-513
10. Almeida O.P., McCaul K., Hankey G.J., Norman P., Jamrozik K., and Flicker L. Homocysteine and depression in later life. Arch. Gen. Psychiatry 65 (2008) 1286-1294
11. Austin M.P., Mitchell P., and Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. Br. J. Psychiatry 178 (2001) 200-206
12. Bao A.M., Meynen G., and Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 57 (2008) 531-553
13. Bell I.R., Edman J.S., Morrow F.D., Marby D.W., Mirages S., Perrone G., Kayne H.L., and Cole J.O. B complex vitamin patterns in geriatric and young adult inpatients with major depression. J. Am. Geriatr. Soc. 39 (1991) 252-257
14. Berg A., Palomaki H., Lehtihalmes M., Lonnqvist J., and Kaste M. Poststroke depression: an 18-month follow-up. Stroke 34 (2003) 138-143
15. Bhogal S.K., Teasell R., Foley N., and Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke 35 (2004) 794-802
16. Bigler E.D., Kerr B., Victoroff J., Tate D.F., and Breitner J.C. White matter lesions, quantitative magnetic resonance imaging, and dementia. Alzheimer Dis. Assoc. Disord. 16 (2002) 161-170
17. Bottiglieri T., Laundy M., Crellin R., Toone B.K., Carney M.W., and Reynolds E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry 69 (2000) 228-232
18. Bouras C., Kovari E., Hof P.R., Riederer B.M., and Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol. 102 (2001) 373-379
19. Bowley M.P., Drevets W.C., Ongur D., and Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52 (2002) 404-412
20. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., Ignatius M.J., et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest 83 (1989) 1015-1031
21. Bozikas V.P., Gold G., Kovari E., Herrmann F., Karavatos A., Giannakopoulos P., and Bouras C. Pathological correlates of poststroke depression in elderly patients. Am. J. Geriatr. Psychiatry 13 (2005) 166-169
22. Bracco L., Campani D., Baratti E., Lippi A., Inzitari D., Pracucci G., and Amaducci L. Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J. Neurol. Sci. 120 (1993) 131-136
23. Bracco L., Piccini C., Moretti M., Mascalchi M., Sforza A., Nacmias B., Cellini E., Bagnoli S., and Sorbi S. Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. Dement. Geriatr. Cogn. Disord. 20 (2005) 358-366
24. Breteler M.M., van Swieten J.C., Bots M.L., Grobbee D.E., Claus J.J., van den Hout J.H., van Harskamp F., Tanghe H.L., de Jong P.T., van Gijn J., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44 (1994) 1246-1252
25. Broadley A.J., Korszun A., Jones C.J., and Frenneaux M.P. Arterial endothelial function is impaired in treated depression. Heart 88 (2002) 521-523
26. Brodaty H., Withall A., Altendorf A., and Sachdev P.S. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study. Am. J. Geriatr. Psychiatry 15 (2007) 477-486
27. Bronge L., Bogdanovic N., and Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement. Geriatr. Cogn. Disord. 13 (2002) 205-212
28. Bruce E.C., and Musselman D.L. Depression, alterations in platelet function, and ischemic heart disease. Psychosom. Med. 67 Suppl. 1 (2005) S34-S36
29. Burvill P.W., Johnson G.A., Jamrozik K.D., Anderson C.S., Stewart-Wynne E.G., and Chakera T.M. Prevalence of depression after stroke: the Perth Community Stroke Study. Br. J. Psychiatry 166 (1995) 320-327
30. Carey C.L., Kramer J.H., Josephson S.A., Mungas D., Reed B.R., Schuff N., Weiner M.W., and Chui H.C. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 39 (2008) 397-402
31. Carney R.M., Freedland K.E., Veith R.C., and Jaffe A.S. Can treating depression reduce mortality after an acute myocardial infarction?. Psychosom. Med. 61 (1999) 666-675
32. Carney R.M., Blumenthal J.A., Freedland K.E., Stein P.K., Howells W.B., Berkman L.F., Watkins L.L., Czajkowski S.M., Hayano J., Domitrovich P.P., and Jaffe A.S. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch. Intern. Med. 165 (2005) 1486-1491
33. Carson A.J., MacHale S., Allen K., Lawrie S.M., Dennis M., House A., and Sharpe M. Depression after stroke and lesion location: a systematic review. Lancet 356 (2000) 122-126
34. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., and Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
35. Chalmers K., Wilcock G.K., and Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol. Appl. Neurobiol. 29 (2003) 231-238
36. Chen C.S., Chen C.C., Kuo Y.T., Chiang I.C., Ko C.H., and Lin H.F. Carotid intima-media thickness in late-onset major depressive disorder. Int. J. Geriatr. Psychiatry 21 (2006) 36-42
37. Cherr G.S., Wang J., Zimmerman P.M., and Dosluoglu H.H. Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization. J. Vasc. Surg. 45 (2007) 744-750
38. Chui H.C. Subcortical ischemic vascular dementia. Neurol. Clin. 25 (2007) 717-740 vi
39. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58 (2001) 545-553
40. Cotter D., Mackay D., Chana G., Beasley C., Landau S., and Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12 (2002) 386-394
41. Craddock D., and Thomas A. Cytokines and late-life depression. Essent. Psychopharmacol. 7 (2006) 42-52
42. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., and Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008) 46-56
43. Davidson R.J., Lewis D.A., Alloy L.B., Amaral D.G., Bush G., Cohen J.D., Drevets W.C., Farah M.J., Kagan J., McClelland J.L., Nolen-Hoeksema S., and Peterson B.S. Neural and behavioral substrates of mood and mood regulation. Biol. Psychiatry 52 (2002) 478-502
44. de Groot J.C., de Leeuw F.E., Oudkerk M., Van Gijn J., Hofman A., Jolles J., and Breteler M.M. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann. Neurol. 52 (2002) 335-341
45. Del Ser T., Bermejo F., Portera A., Arredondo J.M., Bouras C., and Constantinidis J. Vascular dementia. A clinicopathological study. J. Neurol. Sci. 96 (1990) 1-17
46. Drevets W.C., Price J.L., and Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct 213 (2008) 93-118
47. Eaton W.W., Armenian H., Gallo J., Pratt L., and Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 19 (1996) 1097-1102
48. Eaton W.W., Fogel J., and Armenian H.K. The consequences of psychopathology in the Baltimore epidemiologic catchment area follow-up. Medical and psychiatric comorbidity over lifespan (2006), American Psychiatric Publishing, Washington
49. Enzinger C., Fazekas F., Ropele S., and Schmidt R. Progression of cerebral white matter lesions-clinical and radiological considerations. J. Neurol. Sci. 257 (2007) 5-10
50. Esiri M.M., Wilcock G.K., and Morris J.H. Neuropathological assessment of the lesions of significance in vascular dementia. J. Neurol. Neurosurg. Psychiatry 63 (1997) 749-753
51. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., and Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 (1999) 919-920
52. Esiri M.M. Which vascular lesions are of importance in vascular dementia?. Ann. N.Y. Acad. Sci. 903 (2000) 239-243
53. Everson S.A., Roberts R.E., Goldberg D.E., and Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch. Intern. Med. 158 (1998) 1133-1138
54. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., and Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993) 1683-1689
55. Folstein M., Liu T., Peter I., Buell J., Arsenault L., Scott T., and Qiu W.W. The homocysteine hypothesis of depression. Am. J. Psychiatry 164 (2007) 861-867
56. Folstein M.F., Maiberger R., and McHugh P.R. Mood disorder as a specific complication of stroke. J. Neurol. Neurosurg. Psychiatry 40 (1977) 1018-1020
57. Forrester A.W., Lipsey J.R., Teitelbaum M.L., DePaulo J.R., and Andrzejewski P.L. Depression following myocardial infarction. Int. J. Psychiatry Med. 22 (1992) 33-46
58. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 270 (1993) 1819-1825
59. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
60. Fuhrer R., Dufouil C., and Dartigues J.F. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J. Am. Geriatr. Soc. 51 (2003) 1055-1063
61. Fujikawa T., Yamawaki S., and Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 24 (1993) 1631-1634
62. Fujikawa T., Yamawaki S., and Touhouda Y. Background factors and clinical symptoms of major depression with silent cerebral infarction. Stroke 25 (1994) 798-801
63. Garde E., Mortensen E.L., Krabbe K., Rostrup E., and Larsson H.B. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 356 (2000) 628-634
64. Geroldi C., Ferrucci L., Bandinelli S., Cavazzini C., Zanetti O., Guralnik J.M., and Frisoni G.B. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J. Am. Geriatr. Soc. 51 (2003) 1064-1071
65. Giannakopoulos P., Hof P.R., Michel J.P., Guimon J., and Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Brain Res. Rev. 25 (1997) 217-245
66. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., Morrison J.H., Gold G., and Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60 (2003) 1495-1500
67. Gold G., Bouras C., Kovari E., Canuto A., Glaria B.G., Malky A., Hof P.R., Michel J.P., and Giannakopoulos P. Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol. (Berl) 99 (2000) 579-582 discussion 583-4
68. Gold G., Kovari E., Corte G., Herrmann F.R., Canuto A., Bussiere T., Hof P.R., Bouras C., and Giannakopoulos P. Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 946-952
69. Gold G., Kövari E., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., Bouras C., and Giannakopoulos P. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 36 (2005) 1184-1188
70. Gold G., Giannakopoulos P., Herrmann F.R., Bouras C., and Kovari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 130 (2007) 2830-2836
71. Greenberg S.M., Rebeck G.W., Vonsattel J.P., Gomez-Isla T., and Hyman B.T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38 (1995) 254-259
72. Gurol M.E., Irizarry M.C., Smith E.E., Raju S., Diaz-Arrastia R., Bottiglieri T., Rosand J., Growdon J.H., and Greenberg S.M. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66 (2006) 23-29
73. Guttmann C.R., Jolesz F.A., Kikinis R., Killiany R.J., Moss M.B., Sandor T., and Albert M.S. White matter changes with normal aging. Neurology 50 (1998) 972-978
74. Hachinski V.D., Lassen N.A., and Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2 (1974) 207-210
75. Hackett M.L., and Anderson C.S. Predictors of depression after stroke: a systematic review of observational studies. Stroke 36 (2005) 2296-2301
76. Hackett M.L., Yapa C., Parag V., and Anderson C.S. Frequency of depression after stroke: a systematic review of observational studies. Stroke 36 (2005) 1330-1340
77. Hamer M., Tanaka G., Okamura H., Tsuda A., and Steptoe A. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol. Psychol. 74 (2007) 20-25
78. Hamidi M., Drevets W.C., and Price J.L. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol. Psychiatry 55 (2004) 563-569
79. Hankey G.J. Is plasma homocysteine a modifiable risk factor for stroke?. Nat. Clin. Pract. Neurol. 2 (2006) 26-33
80. Harrison P.J. The neuropathology of primary mood disorder. Brain 125 (2002) 1428-1449
81. Hentschel F., Damian M., Krumm B., and Froelich L. White matter lesions-age-adjusted values for cognitively healthy and demented subjects. Acta Neurol. Scand. 115 (2007) 174-180
82. Herbert T.B., and Cohen S. Depression and immunity: a meta-analytic review. Psychol. Bull. 113 (1993) 472-486
83. Herbert T.B., and Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom. Med. 55 (1993) 364-379
84. Herrmann L.L., Le Masurier M., and Ebmeier K.P. White matter hyperintensities in late life depression: a systematic review. J. Neurol. Neurosurg. Psychiatry 79 (2008) 619-624
85. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Brit. J. Psychiat. 140 (1982) 566-572
86. Irwin M.R., and Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21 (2007) 374-383
87. Isingrini E., Desmidt T., Belzung C., and Camus V. Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?. Curr. Opin. Investig. Drugs 10 (2009) 46-55
88. Jacobs B.L., Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 5 (2000) 262-269
89. Jagust W.J., Zheng L., Harvey D.J., Mack W.J., Vinters H.V., Weiner M.W., Ellis W.G., Zarow C., Mungas D., Reed B.R., Kramer J.H., Schuff N., DeCarli C., and Chui H.C. Neuropathological basis of magnetic resonance images in aging and dementia. Ann. Neurol. 63 (2008) 72-80
90. Janszky I., Lekander M., Blom M., Georgiades A., and Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav. Immun. 19 (2005) 555-563
91. Jeerakathil T., Wolf P.A., Beiser A., Massaro J., Seshadri S., D'Agostino R.B., and DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35 (2004) 1857-1861
92. Jellinger K.A., and Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol. (Berl) 105 (2003) 14-17
93. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., and Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 226 (2004) 75-80
94. Kamphuis M.H., Geerlings M.I., Giampaoli S., Nissinen A., Grobbee D.E., and Kromhout D. The association of depression with cardiovascular mortality is partly explained by health status. The FINE Study. J. Affect. Disord. 114 (2009) 184-192
95. Kim J.H., Kim J.W., Ko Y.H., Choi C.U., Na J.O., Kim E.J., Rha S.W., Park C.G., Seo H.S., and Oh D.J. Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery. Int. J. Cardiol. (2009) (Electronic publication ahead of print)
96. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., and Yoon J.S. Vascular risk factors and incident late-life depression in a Korean population. Br. J. Psychiatry 189 (2006) 26-30
97. Kimberly W.T., Gilson A., Rost N.S., Rosand J., Viswanathan A., Smith E.E., and Greenberg S.M. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72 (2009) 1230-1235
98. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., Newman A., Hirsch C., and Tracy R.P. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89 (2002) 419-424
99. Kop W.J., and Gottdiener J.S. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom. Med. 67 Suppl. 1 (2005) S37-S41
100. Kopp M.S., and Rethelyi J. Where psychology meets physiology: chronic stress and premature mortality-the Central-Eastern European health paradox. Brain Res. Bull. 62 (2004) 351-367
101. Korczyn A.D., and Halperin I. Depression and dementia. J. Neurol. Sci. 283 (2009) 139-142
102. Kotila M., Numminen H., Waltimo O., and Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur. J. Neurol. 6 (1999) 309-312
103. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., Bouras C., and Giannakopoulos P. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 (2004) 410-414
104. Krishnan K.R., Hays J.C., and Blazer D.G. MRI-defined vascular depression. Am. J. Psychiatry 154 (1997) 497-501
105. Krishnan K.R., Taylor W.D., McQuoid D.R., MacFall J.R., Payne M.E., Provenzale J.M., and Steffens D.C. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol. Psychiatry 55 (2004) 390-397
106. Kumar A., Miller D., Ewbank D., Yousem D., Newberg A., Samuels S., Cowell P., and Gottlieb G. Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am. J. Geriatr. Psychiatry 5 (1997) 15-25
107. Kumar A., Ajilore O., Kepe V., Barrio J.R., and Small G. Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience. Int. J. Geriatr. Psychiatry 23 (2008) 555-563
108. Lee J.H., Olichney J.M., Hansen L.A., Hofstetter C.R., and Thal L.J. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch. Neurol. 57 (2000) 1474-1479
109. Leentjens A.F., Aben I., Lodder J., and Verhey F.R. General and disease-specific risk factors for depression after ischemic stroke: a two-step Cox regression analysis. Int. Psychogeriatr. 18 (2006) 739-748
110. Lenze E.J., Rogers J.C., Martire L.M., Mulsant B.H., Rollman B.L., Dew M.A., Schulz R., and Reynolds III C.F. The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am. J. Geriatr. Psychiatry 9 (2001) 113-135
111. Loeb C. The history of vascular dementia. J. Hist. Neurosci. 4 (1995) 121-126
112. Longstreth Jr. W.T., Manolio T.A., Arnold A., Burke G.L., Bryan N., Jungreis C.A., Enright P.L., O'Leary D., and Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 (1996) 1274-1282
113. Love S., Miners S., Palmer J., Chalmers K., and Kehoe P. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front. Biosci. 14 (2009) 4778-4792
114. Lu F.P., Lin K.P., and Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE e4144 (2009) 4
115. Lyness J.M., King D.A., Conwell Y., Cox C., and Caine E.D. Cerebrovascular risk factors and 1-year depression outcome in older primary care patients. Am. J. Psychiatry 157 (2000) 1499-1501
116. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995) 11-38
117. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 461 (1999) 25-46
118. Maes M., Van Bockstaele D.R., Gastel A., Song C., Schotte C., Neels H., DeMeester I., Scharpe S., and Janca A. The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology 39 (1999) 1-9
119. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
120. Mast B.T., Miles T., Penninx B.W., Yaffe K., Rosano C., Satterfield S., Ayonayon H.N., Harris T., and Simonsick E.M. Vascular disease and future risk of depressive symptomatology in older adults: findings from the Health, Aging, and Body Composition study. Biol. Psychiatry 64 (2008) 320-326
121. Mayberg H.S., Robinson R.G., Wong D.F., Parikh R., Bolduc P., Starkstein S.E., Price T., Dannals R.F., Links J.M., Wilson A.A., et al. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am. J. Psychiatry 145 (1988) 937-943
122. Meyer A. The anatomical facts and clinical varieties of traumatic insanity. Am. J. Insanity 60 (1904) 373-442
123. Morris M.S., Fava M., Jacques P.F., Selhub J., and Rosenberg I.H. Depression and folate status in the US population. Psychother. Psychosom. 72 (2003) 80-87
124. Morris P.L., Robinson R.G., Andrzejewski P., Samuels J., and Price T.R. Association of depression with 10-year poststroke mortality. Am. J. Psychiatry 150 (1993) 124-129
125. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357 (2001) 169-175
126. Muhtz C., Zyriax B.C., Klahn T., Windler E., and Otte C. Depressive symptoms and metabolic risk: effects of cortisol and gender. Psychoneuroendocrinology 34 (2009) 1004-1011
127. Munoz D.G., Hastak S.M., Harper B., Lee D., and Hachinski V.C. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging. Arch. Neurol. 50 (1993) 492-497
128. Murphy J.M., Monson R.R., Olivier D.C., Sobol A.M., and Leighton A.H. Affective disorders and mortality. A general population study. Arch. Gen. Psychiatry 44 (1987) 473-480
129. Myers P.R., Parker J.L., Tanner M.A., and Adams H.R. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium. Shock 1 (1994) 73-78
130. Naarding P., de Koning I., van Kooten F., Janzing J.G., Beekman A.T., and Koudstaal P.J. Post-stroke dementia and depression: frontosubcortical dysfunction as missing link?. Int. J. Geriatr. Psychiatry 22 (2007) 1-8
131. Naka K.K., Tweddel A.C., Doshi S.N., Goodfellow J., and Henderson A.H. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur. Heart J. 27 (2006) 302-309
132. Navailles S., Hof P.R., and Schmauss C. Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress. J. Comp. Neurol. 509 (2008) 372-381
133. Nys G.M., van Zandvoort M.J., van der Worp H.B., de Haan E.H., de Kort P.L., and Kappelle L.J. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. J. Neurol. Sci. 228 (2005) 27-33
134. O'Brien J., Perry R., Barber R., Gholkar A., and Thomas A. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann. N.Y. Acad. Sci. 903 (2000) 482-489
135. O'Brien S.M., Scott L.V., and Dinan T.G. Antidepressant therapy and C-reactive protein levels. Br. J. Psychiatry 188 (2006) 449-452
136. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., and Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 41 (2007) 326-331
137. Ohira T., Iso H., Satoh S., Sankai T., Tanigawa T., Ogawa Y., Imano H., Sato S., Kitamura A., and Shimamoto T. Prospective study of depressive symptoms and risk of stroke among japanese. Stroke 32 (2001) 903-908
138. Olichney J.M., Hansen L.A., Hofstetter C.R., Grundman M., Katzman R., and Thal L.J. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch. Neurol. 52 (1995) 702-708
139. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., and Thal L.J. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47 (1996) 190-196
140. Olichney J.M., Hansen L.A., Hofstetter C.R., Lee J.H., Katzman R., and Thal L.J. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch. Neurol. 57 (2000) 869-874
141. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13290-13295
142. Paolucci S., Antonucci G., Pratesi L., Traballesi M., Grasso M.G., and Lubich S. Poststroke depression and its role in rehabilitation of inpatients. Arch. Phys. Med. Rehabil. 80 (1999) 985-990
143. Paolucci S., Gandolfo C., Provinciali L., Torta R., and Toso V. The Italian multicenter observational study on post-stroke depression (DESTRO). J. Neurol. 253 (1997) 556-562
144. Paradiso S., Ohkubo T., and Robinson R.G. Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke. Int. J. Psychiatry Med. 253 (2006) 556-562
145. Parikh R.M., Robinson R.G., Lipsey J.R., Starkstein S.E., Fedoroff J.P., and Price T.R. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch. Neurol. 47 (1990) 785-789
146. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., and van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry 58 (2001) 221-227
147. Pohjasvaara T., Mantyla R., Ylikoski R., Kaste M., and Erkinjuntti T. Clinical features of MRI-defined subcortical vascular disease. Alzheimer Dis. Assoc. Disord. 17 (2003) 236-242
148. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., and Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148 (1996) 2083-2095
149. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., and Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am. J. Cardiol. 88 (2001) 196-198 A7
150. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48 (2000) 766-777
151. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., Gorman J.M., and Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry 63 (2006) 161-167
152. Reeves R.R., and Rose E.S. Depression and vascular disease: conceptual issues, relationships and clinical implications. Vasc. Dis. Prevention 3 (2006) 193-203
153. Riediger N.D., Othman R.A., Suh M., and Moghadasian M.H. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Diet. Assoc. 109 (2009) 668-679
154. Rigaud A.S., Traykov L., Caputo L., Coste J., Latour F., Couderc R., Moulin F., Boller F., and Forette F. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology 20 (2001) 268-272
155. Robinson R.G., and Bloom F.E. Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke. Biol. Psychiatry 12 (1977) 669-680
156. Robinson R.G., and Szetela B. Mood change following left hemispheric brain injury. Ann. Neurol. 9 (1981) 447-453
157. Robinson R.G., Kubos K.L., Starr L.B., Rao K., and Price T.R. Mood changes in stroke patients: relationship to lesion location. Compr. Psychiatry 24 (1983) 555-566
158. Robinson R.G., Starr L.B., Kubos K.L., and Price T.R. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke 14 (1983) 736-741
159. Robinson R.G. Post-stroke mood disorders. Hosp. Pract. (Off. Ed.) 21 (1986) 83-89
160. Roman G. Vascular dementia: a historical background. Int. Psychogeriatr. 15(Suppl. 1) (2003) 11-13
161. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., and Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol. 1 (2002) 426-436
162. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am. J. Prev. Med. 23 (2002) 51-61
163. Rybakowski J.K., Wykretowicz A., Heymann-Szlachcinska A., and Wysocki H. Impairment of endothelial function in unipolar and bipolar depression. Biol. Psychiatry 60 (2006) 889-891
164. Sacco R.L. Newer risk factors for stroke. Neurology 57 (2001) S31-S34
165. Santos M., Gold G., Kövari E., Herrmann F.R., Bozikas V.P., Bouras C., and Giannakopoulos P. Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke Aug 20 (2009) (Electronic publication ahead of print)
166. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., and Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45 (1995) 883-888
167. Schmidt R., Schmidt H., Kapeller P., Lechner A., and Fazekas F. Evolution of white matter lesions. Cerebrovasc. Dis. 13 (2002) 16-20
168. Schmidt R., Petrovic K., Ropele S., Enzinger C., and Fazekas F. Progression of leukoaraiosis and cognition. Stroke 38 (2007) 2619-2625
169. Schulz R., Beach S.R., Ives D.G., Martire L.M., Ariyo A.A., and Kop W.J. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Intern. Med. 160 (2000) 1761-1768
170. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
171. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
172. Sherwood A., Hinderliter A.L., Watkins L.L., Waugh R.A., and Blumenthal J.A. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J. Am. Coll. Cardiol. 46 (2005) 656-659
173. Singh A., Herrmann N., and Black S.E. The importance of lesion location in poststroke depression: a critical review. Can. J. Psychiatry 43 (1998) 921-927
174. Smith P.J., Blumenthal J.A., Babyak M.A., Hoffman B.M., Doraiswamy P.M., Waugh R., Hinderliter A., and Sherwood A. Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom. Med. 69 (2007) 578-586
175. Smith P.J., Blumenthal J.A., Babyak M.A., Doraiswamy P.M., Hinderliter A., Hoffman B.M., Waugh R., and Sherwood A. Intima-media thickness and age of first depressive episode. Biol. Psychol. 80 (2009) 361-364
176. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., and Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277 (1997) 813-817
177. Snowdon D.A. Healthy aging and dementia: findings from the Nun Study. Ann. Intern. Med. 139 (2003) 450-454
178. Spalletta G., Bossu P., Ciaramella A., Bria P., Caltagirone C., and Robinson R.G. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol. Psychiatry 11 (2006) 984-991
179. Staekenborg S.S., van Straaten E.C., van der Flier W.M., Lane R., Barkhof F., and Scheltens P. Small vessel versus large vessel vascular dementia : risk factors and MRI findings. J. Neurol. 255 (2008) 1644-1651
180. Starkstein S.E., Robinson R.G., and Price T.R. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 110 Pt 4 (1987) 1045-1059
181. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20 (2006) 112-117
182. Stewart R., Dufouil C., Godin O., Ritchie K., Maillard P., Delcroix N., Crivello F., Mazoyer B., and Tzourio C. Neuroimaging correlates of subjective memory deficits in a community population. Neurology 70 (2008) 1601-1607
183. Streifler J.Y., Rosenberg N., Chetrit A., Eskaraev R., Sela B.A., Dardik R., Zivelin A., Ravid B., Davidson J., Seligsohn U., and Inbal A. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32 (2001) 2753-2758
184. Taylor W.D., MacFall J.R., Payne M.E., McQuoid D.R., Provenzale J.M., Steffens D.C., and Krishnan K.R. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am. J. Psychiatry 161 (2004) 1293-1296
185. Taylor W.D., Macfall J.R., Payne M.E., McQuoid D.R., Steffens D.C., Provenzale J.M., and Krishnan K.R. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol. Med. 37 (2007) 1763-1773
186. Tekin S., and Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 53 (2002) 647-654
187. Thomas A.J., Ferrier I.N., Kalaria R.N., Woodward S.A., Ballard C., Oakley A., Perry R.H., and O'Brien J.T. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am. J. Psychiatry 157 (2000) 1682-1684
188. Thomas A.J., Ferrier I.N., Kalaria R.N., Perry R.H., Brown A., and O'Brien J.T. A neuropathological study of vascular factors in late-life depression. J. Neurol. Neurosurg. Psychiatry 70 (2001) 83-87
189. Thomas A.J., Ferrier I.N., Kalaria R.N., Davis S., and O'Brien J.T. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br. J. Psychiatry 181 (2002) 129-134
190. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., and O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am. J. Psychiatry 162 (2005) 175-177
191. Thomas A.J., and O'Brien J.T. Depression and cognition in older adults. Curr. Opin. Psychiatry 21 (2008) 8-13
192. Tiemeier H., Hofman A., van Tuijl H.R., Kiliaan A.J., Meijer J., and Breteler M.M. Inflammatory proteins and depression in the elderly. Epidemiology 14 (2003) 103-107
193. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 7 (1968) 331-356
194. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of demented old people. J. Neurol. Sci. 11 (1970) 205-242
195. Udaka F., Sawada H., and Kameyama M. White matter lesions and dementia: MRI-pathological correlation. Ann. N.Y. Acad. Sci. 977 (2002) 411-415
196. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., and Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 67 (2004) 269-275
197. Vaccarino V., Brennan M.L., Miller A.H., Bremner J.D., Ritchie J.C., Lindau F., Veledar E., Su S., Murrah N.V., Jones L., Jawed F., Fazekas F., Dai J., Goldberg J., and Hazen S.L. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol. Psychiatry 64 (2008) 476-483
198. van der Flier W.M., van Straaten E.C., Barkhof F., Verdelho A., Madureira S., Pantoni L., Inzitari D., Erkinjuntti T., Crisby M., Waldemar G., Schmidt R., Fazekas F., and Scheltens P. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 36 (2005) 2116-2120
199. van Swieten J.C., van den Hout J.H., van Ketel B.A., Hijdra A., Wokke J.H., and van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114 Pt. 2 (1991) 761-774
200. van West D., and Maes M. Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuro. Endocrinol. Lett. 20 (1999) 11-17
201. Vataja R., Pohjasvaara T., Leppavuori A., Mantyla R., Aronen H.J., Salonen O., Kaste M., and Erkinjuntti T. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch. Gen. Psychiatry 58 (2001) 925-931
202. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R., et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51 (1994) 411-422
203. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348 (2003) 1215-1222
204. Vernooij M.W., Ikram M.A., Tanghe H.L., Vincent A.J., Hofman A., Krestin G.P., Niessen W.J., Breteler M.M., and van der Lugt A. Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357 (2007) 1821-1828
205. Vinters H.V., Ellis W.G., Zarow C., Zaias B.W., Jagust W.J., Mack W.J., and Chui H.C. Neuropathologic substrates of ischemic vascular dementia. J. Neuropathol. Exp. Neurol. 59 (2000) 931-945
206. Wang S.H., Zhang Z.J., Guo Y.J., Teng G.J., and Chen B.A. Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress. Behav. Brain Res. 189 (2008) 9-16
207. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
208. West R.L. An application of prefrontal cortex function theory to cognitive aging. Psychol. Bull. 120 (1996) 272-292
209. Whooley M.A., Caska C.M., Hendrickson B.E., Rourke M.A., Ho J., and Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry 62 (2007) 314-320
210. Whyte E.M., and Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol. Psychiatry 52 (2002) 253-264
211. Whyte E.M., Mulsant B.H., Vanderbilt J., Dodge H.H., and Ganguli M. Depression after stroke: a prospective epidemiological study. J. Am. Geriatr. Soc. 52 (2004) 774-778
212. Williams S.A., Kasl S.V., Heiat A., Abramson J.L., Krumholz H.M., and Vaccarino V. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom. Med. 64 (2002) 6-12
213. Yen Y.C., Rebok G.W., Gallo J.J., Yang M.J., Lung F.W., and Shih C.H. ApoE4 allele is associated with late-life depression: a population-based study. Am. J. Geriatr. Psychiatry 15 (2007) 858-868
214. Ylikoski R., Ylikoski A., Erkinjuntti T., Sulkava R., Raininko R., and Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch. Neurol. 50 (1993) 818-824
215. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
216. Zekry D., Duyckaerts C., Moulias R., Belmin J., Geoffre C., Herrmann F., and Hauw J.J. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol. (Berl) 103 (2002) 481-487
217. Ziegelstein R.C., Parakh K., Sakhuja A., and Bhat U. Platelet function in patients with major depression. Intern. Med. J. 39 (2009) 38-43
218. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., and Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226